• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用癌症蛋白质组图谱探索、可视化和分析功能性癌症蛋白质组数据。

Explore, Visualize, and Analyze Functional Cancer Proteomic Data Using the Cancer Proteome Atlas.

作者信息

Li Jun, Akbani Rehan, Zhao Wei, Lu Yiling, Weinstein John N, Mills Gordon B, Liang Han

机构信息

Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

出版信息

Cancer Res. 2017 Nov 1;77(21):e51-e54. doi: 10.1158/0008-5472.CAN-17-0369.

DOI:10.1158/0008-5472.CAN-17-0369
PMID:29092939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5679242/
Abstract

Reverse-phase protein arrays (RPPA) represent a powerful functional proteomic approach to elucidate cancer-related molecular mechanisms and to develop novel cancer therapies. To facilitate community-based investigation of the large-scale protein expression data generated by this platform, we have developed a user-friendly, open-access bioinformatic resource, The Cancer Proteome Atlas (TCPA, http://tcpaportal.org), which contains two separate web applications. The first one focuses on RPPA data of patient tumors, which contains >8,000 samples of 32 cancer types from The Cancer Genome Atlas and other independent patient cohorts. The second application focuses on the RPPA data of cancer cell lines and contains >650 independent cell lines across 19 lineages. Many of these cell lines have publicly available, high-quality DNA, RNA, and drug screening data. TCPA provides various analytic and visualization modules to help cancer researchers explore these datasets and generate testable hypotheses in an effective and intuitive manner. .

摘要

反相蛋白质阵列(RPPA)是一种强大的功能蛋白质组学方法,用于阐明癌症相关分子机制并开发新型癌症疗法。为了促进基于社区对该平台产生的大规模蛋白质表达数据的研究,我们开发了一个用户友好、开放获取的生物信息资源——癌症蛋白质组图谱(TCPA,http://tcpaportal.org),它包含两个独立的网络应用程序。第一个专注于患者肿瘤的RPPA数据,其中包含来自癌症基因组图谱和其他独立患者队列的32种癌症类型的8000多个样本。第二个应用程序专注于癌细胞系的RPPA数据,包含19个谱系的650多个独立细胞系。这些细胞系中的许多都有公开可用的高质量DNA、RNA和药物筛选数据。TCPA提供各种分析和可视化模块,以帮助癌症研究人员有效且直观地探索这些数据集并生成可检验的假设。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a8/5679242/84a90143add9/nihms898947f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a8/5679242/84a90143add9/nihms898947f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a8/5679242/84a90143add9/nihms898947f1.jpg

相似文献

1
Explore, Visualize, and Analyze Functional Cancer Proteomic Data Using the Cancer Proteome Atlas.使用癌症蛋白质组图谱探索、可视化和分析功能性癌症蛋白质组数据。
Cancer Res. 2017 Nov 1;77(21):e51-e54. doi: 10.1158/0008-5472.CAN-17-0369.
2
TCPA v3.0: An Integrative Platform to Explore the Pan-Cancer Analysis of Functional Proteomic Data.TCPA v3.0:一个综合平台,用于探索功能蛋白质组学数据的泛癌分析。
Mol Cell Proteomics. 2019 Aug 9;18(8 suppl 1):S15-S25. doi: 10.1074/mcp.RA118.001260. Epub 2019 Jun 14.
3
Using feature selection and Bayesian network identify cancer subtypes based on proteomic data.基于蛋白质组学数据,使用特征选择和贝叶斯网络识别癌症亚型。
J Proteomics. 2023 May 30;280:104895. doi: 10.1016/j.jprot.2023.104895. Epub 2023 Apr 5.
4
The ISB Cancer Genomics Cloud: A Flexible Cloud-Based Platform for Cancer Genomics Research.国际生物信息学研究所癌症基因组云平台:一个用于癌症基因组学研究的灵活的基于云的平台。
Cancer Res. 2017 Nov 1;77(21):e7-e10. doi: 10.1158/0008-5472.CAN-17-0617.
5
The Cancer Genomics Cloud: Collaborative, Reproducible, and Democratized-A New Paradigm in Large-Scale Computational Research.癌症基因组学云:协作、可重复且民主化——大规模计算研究的新范式
Cancer Res. 2017 Nov 1;77(21):e3-e6. doi: 10.1158/0008-5472.CAN-17-0387.
6
WebMeV: A Cloud Platform for Analyzing and Visualizing Cancer Genomic Data.WebMeV:一个用于分析和可视化癌症基因组数据的云平台。
Cancer Res. 2017 Nov 1;77(21):e11-e14. doi: 10.1158/0008-5472.CAN-17-0802.
7
Analytical Platforms 3: Processing Samples via the RPPA Pipeline to Generate Large-Scale Data for Clinical Studies.分析平台 3:通过 RPPA 管道处理样本,为临床研究生成大规模数据。
Adv Exp Med Biol. 2019;1188:113-147. doi: 10.1007/978-981-32-9755-5_7.
8
LinkedOmics: analyzing multi-omics data within and across 32 cancer types.LinkedOmics:在 32 种癌症类型内和类型间分析多组学数据。
Nucleic Acids Res. 2018 Jan 4;46(D1):D956-D963. doi: 10.1093/nar/gkx1090.
9
The Encyclopedia of Proteome Dynamics: a big data ecosystem for (prote)omics.蛋白质组动力学百科全书:一个用于(蛋白质组学)的大数据生态系统。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1202-D1209. doi: 10.1093/nar/gkx807.
10
TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer.TANRIC:一个用于探索长链非编码RNA在癌症中功能的交互式开放平台。
Cancer Res. 2015 Sep 15;75(18):3728-37. doi: 10.1158/0008-5472.CAN-15-0273. Epub 2015 Jul 24.

引用本文的文献

1
JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer.JNK信号通路抑制介导雌激素受体阳性乳腺癌对联合内分泌治疗和CDK4/6抑制的不敏感性。
J Exp Clin Cancer Res. 2025 Aug 19;44(1):244. doi: 10.1186/s13046-025-03466-9.
2
Stathmin Serine 16 Phosphorylation Is a Key Regulator of Cell Cycle Progression Without Activating Migration and Invasion In Vitro.Stathmin丝氨酸16磷酸化是细胞周期进程的关键调节因子,且不会在体外激活迁移和侵袭。
Cancers (Basel). 2025 Jul 12;17(14):2322. doi: 10.3390/cancers17142322.
3
Genes driving three-dimensional growth of immortalized cells and cancer.

本文引用的文献

1
Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays.利用反相蛋白质阵列对人癌细胞系进行表征
Cancer Cell. 2017 Feb 13;31(2):225-239. doi: 10.1016/j.ccell.2017.01.005.
2
E-cadherin expression and prognosis of head and neck squamous cell carcinoma: evidence from 19 published investigations.E-钙黏蛋白表达与头颈部鳞状细胞癌的预后:来自19项已发表研究的证据。
Onco Targets Ther. 2016 Apr 26;9:2447-53. doi: 10.2147/OTT.S98577. eCollection 2016.
3
Development of a robust classifier for quality control of reverse-phase protein arrays.
驱动永生化细胞和癌细胞三维生长的基因。
Cell Death Dis. 2025 Jun 10;16(1):442. doi: 10.1038/s41419-025-07719-5.
4
Melanoma Proteomics Unveiled: Harmonizing Diverse Data Sets for Biomarker Discovery and Clinical Insights via MEL-PLOT.黑色素瘤蛋白质组学揭秘:通过MEL-PLOT整合多样数据集以发现生物标志物并获得临床见解
J Proteome Res. 2025 Jun 6;24(6):3117-3128. doi: 10.1021/acs.jproteome.4c00749. Epub 2025 May 5.
5
A Multi-Omics Analysis of a Mitophagy-Related Signature in Pan-Cancer.泛癌中与线粒体自噬相关特征的多组学分析
Int J Mol Sci. 2025 Jan 7;26(2):448. doi: 10.3390/ijms26020448.
6
Orchestrated desaturation reprogramming from stearoyl-CoA desaturase to fatty acid desaturase 2 in cancer epithelial-mesenchymal transition and metastasis.在癌症上皮-间质转化和转移过程中,从硬脂酰辅酶A去饱和酶到脂肪酸去饱和酶2的协同去饱和重编程。
Cancer Commun (Lond). 2025 Mar;45(3):245-280. doi: 10.1002/cac2.12644. Epub 2024 Dec 25.
7
Navigating the oncology drug discovery and development process with programmes supported by the National Institutes of Health.借助美国国立卫生研究院支持的项目,探索肿瘤学药物发现与开发过程。
Lancet Oncol. 2024 Dec;25(12):e685-e693. doi: 10.1016/S1470-2045(24)00348-6.
8
Reproducible processing of TCGA regulatory networks.TCGA调控网络的可重复性处理。
bioRxiv. 2024 Nov 7:2024.11.05.622163. doi: 10.1101/2024.11.05.622163.
9
Comprehensive pan-cancer analysis and experiments revealed R3HDM1 as a novel predictive biomarker for prognosis and immune therapy response.全面的泛癌分析和实验表明,R3HDM1是一种用于预测预后和免疫治疗反应的新型生物标志物。
Front Genet. 2024 Sep 23;15:1404348. doi: 10.3389/fgene.2024.1404348. eCollection 2024.
10
Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer.新型蛋白预后标志物与卵巢癌免疫治疗疗效相关。
J Ovarian Res. 2024 Sep 28;17(1):190. doi: 10.1186/s13048-024-01518-w.
用于反相蛋白质阵列质量控制的稳健分类器的开发。
Bioinformatics. 2015 Mar 15;31(6):912-8. doi: 10.1093/bioinformatics/btu736. Epub 2014 Nov 6.
4
A pan-cancer proteomic perspective on The Cancer Genome Atlas.基于癌症基因组图谱的泛癌蛋白质组学视角。
Nat Commun. 2014 May 29;5:3887. doi: 10.1038/ncomms4887.
5
The Cancer Genome Atlas Pan-Cancer analysis project.癌症基因组图谱泛癌分析项目。
Nat Genet. 2013 Oct;45(10):1113-20. doi: 10.1038/ng.2764.
6
TCPA: a resource for cancer functional proteomics data.TCPA:癌症功能蛋白质组学数据资源
Nat Methods. 2013 Nov;10(11):1046-7. doi: 10.1038/nmeth.2650. Epub 2013 Sep 15.
7
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers.非显微切割人类乳腺癌中反向蛋白质阵列在功能蛋白质组学研究中的效用的技术评估。
Clin Proteomics. 2010 Dec;6(4):129-51. doi: 10.1007/s12014-010-9055-y.
8
Reverse-phase protein lysate microarrays for cell signaling analysis.用于细胞信号分析的反相蛋白质裂解物微阵列
Nat Protoc. 2008;3(11):1796-808. doi: 10.1038/nprot.2008.179.
9
Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.反相蛋白质阵列:一种新型蛋白质组学技术的验证及其在原发性白血病标本和造血干细胞分析中的应用
Mol Cancer Ther. 2006 Oct;5(10):2512-21. doi: 10.1158/1535-7163.MCT-06-0334.
10
Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma.使用反相蛋白质微阵列和参考标准开发进行转移性卵巢癌的分子网络分析。
Mol Cell Proteomics. 2005 Apr;4(4):346-55. doi: 10.1074/mcp.T500003-MCP200. Epub 2005 Jan 25.